Cibc World Markets Corp Xeris Biopharma Holdings, Inc. Transaction History
Cibc World Markets Corp
- $14.8 Billion
- Q2 2025
A detailed history of Cibc World Markets Corp transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 18,473 shares of XERS stock, worth $180,296. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,473
Previous 31,115
40.63%
Holding current value
$180,296
Previous $170,000
49.41%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding XERS
# of Institutions
215Shares Held
89.8MCall Options Held
81.6KPut Options Held
57.6K-
Black Rock Inc. New York, NY10.3MShares$101 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$95.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.84MShares$37.4 Million0.01% of portfolio
-
State Street Corp Boston, MA3.78MShares$36.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.65MShares$35.6 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $1.33B
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...